Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks

Abstract

In a search for molecular markers of progression in prostate cancer by means of differential display, we have identified a new gene, which we have designated PTOV1. Semiquantitative RT–PCR has established that nine out of 11 tumors overexpress PTOV1 at levels significantly higher than benign prostatic hyperplasia or normal prostate tissue. The human PTOV1 protein consists almost entirely of two repeated blocks of homology of 151 and 147 amino acids, joined by a short linker peptide, and is encoded by a 12-exon gene localized in chromosome 19q13.3. A Drosophila melanogaster PTOV1 homolog also contains two tandemly arranged PTOV blocks. A second gene, PTOV2, was identified in humans and Drosophila, coding for proteins with a single PTOV homology block and unrelated amino- and carboxyl-terminal extensions. A 1.8-Kb PTOV1 transcript was detected abundantly in normal human brain, heart, skeletal muscle, kidney and liver, and at low levels in normal prostate. Immunocytochemical analysis and expression of chimeric GFP-PTOV1 proteins in cultured cells showed a predominantly perinuclear localization of PTOV1. In normal prostate tissue and in prostate adenomas, PTOV1 was undetectable or expressed at low levels, whereas nine out of 11 prostate adenocarcinomas showed a strong immunoreactivity, with a focal distribution in areas of carcinoma and prostatic intraepithelial neoplasia. Therefore, PTOV1 is a previously unknown gene, overexpressed in early and late stages of prostate cancer. The PTOV homology block represents a new class of conserved sequence blocks present in human, rodent and fly proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, Scherer SE, Li PW, Hoskins RA, Galle RF, et al. 2000 Science 287: 2185–2195

  • Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ . 1990 J. Mol. Biol. 215: 403–410

  • Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ . 1997 Nucleic Acids Res. 25: 3389–3402

  • Blok LJ, Kumar MV, Tindall DJ . 1995 Prostate 26: 213–224

  • Bostwick DG . 1996 Cancer 78: 330–336

  • Bostwick DG, Pacelli A, Lopez-Beltran A . 1997 Prostate 33: 32–37

  • Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, Cheng L . 1998 Cancer 83: 1995–2002

  • Brooks JD, Bova GS, Ewing CM, Piantadosi S, Carter BS, Robinson JE, Epstein JI, Isaacs WB . 1996 Cancer Res. 56: 3814–3822

  • Burge C, Karlin S . 1997 J. Mol. Biol. 268: 78–94

  • Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ, Brinkmann AO . 1997 Cancer Res. 57: 4075–4081

  • Diamandis EP, Yousef GM, Luo I, Magklara I, Obiezu CV . 2000 Trends Endocrinol. Metab. 11: 54–60

  • Fan S, Wang JA, Yuan RQ, Ma YX, Meng Q, Erdos MR, Brody LC, Goldberg ID, Rosen EM . 1998 Oncogene 16: 3069–3082

  • Fernández PL, Arce Y, Farr X, Martínez A, Nadal A, Rey MJ, Peir N, Campo E, Cardesa A . 1999 J. Pathol. 187: 563–566

  • Gottlieb B, Beitel LK, Lumbroso R, Pinsky L, Trifiro M . 1999 Hum. Mutat. 14: 103–114

  • Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V . 1998 Cancer Res. 58: 4782–4786

  • Guate JL, Fernandez N, Lanzas JM, Escaf S, Vega JA . 1999 BJU Int. 84: 495–502

  • Guigó R, Knudsen S, Drake N, Smith T . 1992 J. Mol. Biol. 226: 141–157

  • Harper ME, Glynne-Jones E, Goddard L, Mathews P, Nicholson RI . 1998 J. Pathol. 186: 169–177

  • He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EP, Abate-Shen C, Carter KC . 1997 Genomics 43: 69–77

  • Jenster G . 1999 Semin. Oncol. 26: 407–421

  • Johnson MI, Robinson MC, Marsh C, Robson CN, Neal DE, Hamdy FC . 1998 Prostate 37: 223–229

  • Kallionemi OP, Visakorpi T . 1996 Adv. Cancer Res. 68: 225–255

  • Liang P, Pardee AB . 1992 Science 257: 967–971

  • Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, Hood L, Nelson PS . 1999 Cancer Res. 59: 4180–4184

  • López-Otín C, Diamandis EP . 1998 Endocrinol. Rev. 19: 365–396

  • Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T . 1998 Cancer Res. 58: 743–752

  • Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M . 1997 Lab. Invest. 76: 37–51

  • Meyers FJ, Gumerlock PH, Chi SG, Borchers H, Deitch AD, deVere White RW . 1998 Cancer 83: 2534–2539

  • Montironi R, Mazzucchelli R, Pomante R, Thompson D, Duval da Silva V, Vaught L, Bartels PH . 1999 J. Clin. Pathol. 52: 350–354

  • Nogales E, Wolf SG, Downing KH . 1998 Nature 391: 199–203

  • Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wah IM, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON . 1998 Proc. Natl. Acad. Sci. USA 95: 1735–1740

  • Rondinelli RH, Tricoli JV . 1999 Clin. Cancer Res. 5: 1595–1602

  • Shen R, Su ZZ, Olsson CA, Fisher PB . 1995 Proc. Natl. Acad. Sci. USA 92: 6778–6782

  • Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB . 1996 Science 274: 1371–1374

  • Stubbs AP, Abel PD, Golding M, Bhangal G, Wang Q, Waxman J, Stamp GW, Lalani EN . 1999 Am. J. Pathol. 154: 1335–1343

  • Sudhof TC, Czernik AJ, Kao HT, Takei K, Johnston PA, Horiuchi A, Kanazir SD, Wagner MA, Perin MS, De Camilli P, et al. 1989 Science 245: 1474–1480

  • Sun Y, Lin J, Katz AE, Fisher PB . 1997 Cancer Res. 57: 18–23

  • Troyer JK, Beckett ML, Wright Jr GL . 1995 Int. J. Cancer 62: 552–558

  • Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB . 1996 Cancer Res. 56: 3634–3637

  • Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL . 1998 Proc. Natl. Acad. Sci. USA 95: 5246–5250

  • Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP . 1999 Genomics 62: 251–259

  • Yousef GM, Scorilas A, Diamandis EP . 2000 Genomics 63: 88–96

  • Zhau HE, Wan DS, Zhou J, Miller GJ, von Eschenbach AC . 1992 Mol. Carcinog. 5: 320–327

Download references

Acknowledgements

We are grateful to G Parra and R Guigó for expert assistance in the prediction of gene structures, to F Munell for continued support, and to R Serrano for technical help. This work was funded by grants FIS 98/0199 (to J Reventós), PB97-1170 (to TM Thomson), SAF97-0084 and Marató TV3 (to R Paciucci). P Benedit is a recipient of a fellowship from the CIRIT, Catalunya, Spain. M Valeri was supported by a studentship from the Fundació per a la Recerca Vall d'Hebrón, Barcelona.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benedit, P., Paciucci, R., Thomson, T. et al. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene 20, 1455–1464 (2001). https://doi.org/10.1038/sj.onc.1204233

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204233

Keywords

This article is cited by

Search

Quick links